In March 2008, the Karolinska Institute identified 37 genes associated with this compound. The mevalonate pathway for its synthesis is targeted by HMG-CoA reductase inhibitors, also known as statins, which are used to lower its quantity in humans. In animal cells, its molecules are present between phospholipid tails throughout cell membranes, promoting the stability of the membrane. The major constituent of gall stones, for 10 points, identify this molecule whose harmful LDL form can lead to cardiovascular diseases.
In March 2008, the Karolinska Institute identified 37 genes associated with this compound. The mevalonate pathway for its synthesis is targeted by HMG-CoA reductase inhibitors, also known as statins, which are used to lower its quantity in humans. In animal cells, its molecules are present between phospholipid tails throughout cell membranes, promoting the stability of the membrane. The major constituent of gall stones, for 10 points, identify this molecule whose harmful LDL form can lead to cardiovascular diseases.
In March 2008, the Karolinska Institute identified 37 genes associated with this compound.
{cholesterol}